Related Experiment Video

Updated: Jun 18, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions

Michael Kaplan1, Cathy Hammerman

  • 1Department of Neonatology, Shaare Zedek Medical Center, Faculty of Medicine of the Hebrew University, Jerusalem, Israel. kaplan@cc.huji.ac.il

Seminars in Fetal & Neonatal Medicine
|November 28, 2009
PubMed

Insights

Glucose-6-phosphate dehydrogenase deficiency is a common genetic disorder causing hemolysis and dangerous bilirubin increases. Neonatal screening and education are key to preventing severe outcomes and neurologic damage.

Area of Science:

  • Genetics
  • Pediatrics
  • Hematology

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent global genetic condition.
  • Hemolytic episodes in G6PD deficiency can lead to severe hyperbilirubinemia.
  • Elevated bilirubin levels pose a risk for bilirubin-induced neurologic damage.

Purpose of the Study:

  • To highlight the risks associated with Glucose-6-phosphate dehydrogenase deficiency.
  • To emphasize the importance of managing hyperbilirubinemia in affected neonates.
  • To discuss preventative strategies for G6PD deficiency complications.

Main Methods:

  • Review of existing literature on G6PD deficiency and hyperbilirubinemia.
  • Analysis of the complex gene-environment interactions influencing bilirubin levels.
  • Evaluation of the impact of neonatal screening and educational interventions.

Main Results:

  • G6PD deficiency can cause rapid, significant increases in serum total bilirubin.
  • Hyperbilirubinemia results from intricate genetic and environmental factors.
  • Neonatal screening and education show promise in mitigating disease severity.

Conclusions:

  • Effective management of G6PD deficiency requires understanding its genetic basis and environmental triggers.
  • Early detection through neonatal screening is crucial for preventing severe hyperbilirubinemia and neurologic sequelae.
  • Parental and medical education are vital components in managing G6PD deficiency and its complications.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pedigree Analysis01:35

Pedigree Analysis

Overview
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...